The U.S. Food and Drug Administration (FDA) recently updated the webpage, Questions and Answers Regarding Carbadox, to address questions about the FDA’s proposal to revoke the approved regulatory method for carbadox. Included in the website is a response to the question, “What is the expected impact of this action on the swine industry?”
Phibro Animal Health issued a press release in response.
The FDA is accepting public comments until September 18, 2020. Submit comments by visiting www.federalregister.gov